A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Ulcerative Colitis
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Filgotinib (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms MANTA
- Sponsors Gilead Sciences
- 15 Aug 2017 Planned number of patients changed from 200 to 250.
- 19 Jul 2017 Status changed from not yet recruiting to recruiting.
- 26 May 2016 New trial record